Literature DB >> 24846773

Sleep and Alzheimer's disease.

Laure Peter-Derex1, Pierre Yammine2, Hélène Bastuji3, Bernard Croisile4.   

Abstract

Sleep disorders are frequent in Alzheimer's disease (AD), with a significant impact on patients and caregivers and a major risk factor for early institutionalization. Micro-architectural sleep alterations, nocturnal sleep fragmentation, decrease in nocturnal sleep duration, diurnal napping and even inversion of the sleep-wake cycle are the main disorders observed in patients with AD. Experimental and epidemiological evidence for a close reciprocal interaction between cognitive decline and sleep alterations is growing. Management of sleep disorders in AD is pre-eminently behavioral. Association of melatonin and bright light treatment seems to be promising as well. The presence of sleep complaints, especially excessive somnolence in demented patients, should draw attention to possible associated sleep pathologies such as sleep apnea syndrome or restless legs syndrome.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Memory; Sleep disturbance

Mesh:

Year:  2014        PMID: 24846773     DOI: 10.1016/j.smrv.2014.03.007

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  104 in total

Review 1.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

2.  Dysfunction of GABAergic neurons in the parafacial zone mediates sleep disturbances in a streptozotocin-induced rat model of sporadic Alzheimer's disease.

Authors:  Jin-Zhi Song; Su-Ying Cui; Xiang-Yu Cui; Xiao Hu; Yu-Nu Ma; Hui Ding; Hui Ye; Yong-He Zhang
Journal:  Metab Brain Dis       Date:  2017-10-28       Impact factor: 3.584

Review 3.  Sleep disruption and quality of life in persons with dementia: A state-of-the-art review.

Authors:  Darina V Petrovsky; Miranda Varrasse McPhillips; Junxin Li; Ariana Brody; Laurel Caffeé; Nancy A Hodgson
Journal:  Geriatr Nurs       Date:  2018-05-24       Impact factor: 2.361

Review 4.  Sleep, Cognition and Dementia.

Authors:  Verna R Porter; William G Buxton; Alon Y Avidan
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 5.  Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease.

Authors:  Luigi Ferini-Strambi; Andrea Galbiati; Francesca Casoni; Maria Salsone
Journal:  Curr Treat Options Neurol       Date:  2020-02-05       Impact factor: 3.598

6.  Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies.

Authors:  Kathryn Richardson; George M Savva; Penelope J Boyd; Clare Aldus; Ian Maidment; Eduwin Pakpahan; Yoon K Loke; Antony Arthur; Nicholas Steel; Clive Ballard; Robert Howard; Chris Fox
Journal:  Health Technol Assess       Date:  2021-01       Impact factor: 4.014

Review 7.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

Review 8.  The neurobiological basis of sleep: Insights from Drosophila.

Authors:  Sarah Ly; Allan I Pack; Nirinjini Naidoo
Journal:  Neurosci Biobehav Rev       Date:  2018-01-31       Impact factor: 8.989

Review 9.  Effects of exercise on sleep in neurodegenerative disease.

Authors:  Adeel A Memon; Juliana J Coleman; Amy W Amara
Journal:  Neurobiol Dis       Date:  2020-04-01       Impact factor: 5.996

10.  Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease.

Authors:  Erik S Musiek; Meghana Bhimasani; Margaret A Zangrilli; John C Morris; David M Holtzman; Yo-El S Ju
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.